NEW YORK, Nov. 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

http://www.reportlinker.com/p0681347/China-Healthcare-Reform-and-Its-Impact-on-IVD-Medical-Device-and-Pharmaceutical-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Health_Insurance

China's rapid economic development and numerous steps of reform undertaken by the Chinese central government since 1997 had clear and observable effects upon China's total healthcare services market and product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, including increased funding, to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers. Analyst Emil Salazar focuses on these questions.

The report contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:

• Statistics on Chinese Hospitals, Community Health Centers and Clinics
• Top and Bottom City Markets for Urban Healthcare
• Top and Bottom Rural Regions
• Challenges for Foreign-Owned MNCs in China
• Government Healthcare Spending
• Foreign-Invested Manufacturing Enterprises in China
• Share of Government Funded Healthcare vs. Out of Pocket
• Domestic Healthcare Industries
• Population and Age Statistics
• Incidence Rates for Infectious Diseases
• Cancer Rates in China
• Regulation of Drugs and Devices in China
• U.S. Product Exports to China
• Key Analyst Conclusions

CHAPTER ONE: EXECUTIVE SUMMARY

Healthcare in China

Healthcare Reform and Market Impact

Rural Healthcare Market in Era of Reform

Urban Healthcare Market in Era of Reform

China's IVD Market in an Era of Reform

China's Medical Devices Market in an Era of Reform

China's Pharmaceuticals Market in an Era of Reform

Major Findings

CHAPTER TWO: HEALTHCARE IN CHINA - PRIMARY INDICATORS AND A NEED FOR REFORM

Introduction

Barefoot Doctors and the Rural Cooperative Medical Scheme (RCMS)

China's Economic Reform Impacts Healthcare

New Rural Cooperative Medical Scheme (NRCMS) and Government Recommitment to Reform

China on the Eve of Contemporary Healthcare Reform

CHAPTER THREE: CHINA'S "REFORM" HEALTHCARE MARKET AND ITS SHAPING OF RURAL, URBAN, REGIONAL AND PROVINCIAL MARKETS

Introduction

China's 2009-2011 Healthcare Reform in Its Main Features and Provisions

Healthcare Reform on the "Grassroots" Level - The Many Chinas in Focus

The Contemporary Rural Healthcare Market in China - Major Regions, Institutions and Landscape

Rural China Healthcare Market from the NRCMS to the End of Healthcare Reform under the 12th Five-Year Plan (2004-2015) - Historical and Projected Market Sizes and Segmentation

Urban Healthcare Markets in China and their Trajectory through Reform (2004-2015)

Foreign Medical Product Suppliers Penetrate the Chinese Market

CHAPTER FOUR: DIAGNOSTICS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

Introduction

Demand-Side Drivers in the Chinese IVD Market

Diabetes

Cancer

Allergy

Infectious Disease

Healthcare System/ Reform Supply-Side Drivers

Physician Office Laboratories (POL

Self-Testing

Hospital and Private Laboratories

Research and Technology Sector

Market Size and Projections

Market Distribution and The State of The Industry

Domestic Chinese IVD Industry

Regulation

CHAPTER FIVE: MEDICAL DEVICES IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

Introduction

Demand-Side Drivers in the Chinese Medical Device Market

Cancer

Cardiovascular Diseases

Aging

Healthcare System/Reform - Supply-Side Drivers

Hospitals

Specialty Treatment Clinics

Public Clinics, Health Centers and "Grass Roots" Medical Institutions

Market Size and Projections

Market Distribution and the State of the Industry

Foreign Manufacturers

Domestic Chinese IVD Industry

Regulation

Manufacturing Enterprise Approvals

Cost Controls for Medical Procedures and Reimbursements

Device Approval

CHAPTER SIX: PHARMACEUTICALS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

Introduction

Demand-Side Drivers in the Chinese Pharmaceuticals Market

Diabetes

Hypertension and Heart Disease

Cancer

Infectious Diseases

Self-Medication

Supply-Side Drivers (Healthcare Reform) and Market Channels

Hospital Pharmacies

Retail Pharmacies

Other Commercial Channels - Mass Merchants, Mail Order and Online

Market Size and Projections

MARKET DISTRIBUTION AND THE STATE OF THE INDUSTRY

"Big Pharma" - western MNCs in China

Domestic Chinese Pharma Industry

REGULATION

Manufacturing Enterprise Approvals

Pricing Controls at Manufacturer-Level

Pricing Controls at Pharmacy-Level

Drug Approval

Intellectual Property Protection (IPP)

CHAPTER SEVEN: CONCLUSIONS

Conclusion One

Conclusion Two

Conclusion Three

Conclusion Four

Conclusion Five

Conclusion Six

Conclusion Seven

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: Government-Run Urban Health Insurance Programs in China

Figure 1-1: Chinese Healthcare Reform Government Funding Breakdown (2009-2011)

Figure 1-2: Rural and Urban China Healthcare Market (Insurance and Out-of-Pocket Payments) (2004-2015) (billion yuan)

Figure 1-3: IVD, Pharmaceuticals and Medical Devices Markets in China (2004-2015) (billions $)

CHAPTER TWO: HEALTHCARE IN CHINA - PRIMARY INDICATORS AND A NEED FOR REFORM

Figure 2-1: Chinese National Population (% Urban/Rural)

Figure 2-2: Chinese Government Health Expenditures (in billion yuan and % of total health expenditures) (1980-2009)

Figure 2-3: Average Inpatient Visit Costs and Bed Utilization at Chinese Public Hospitals (1985-2010)

Figure 2-4: Gross National Income (GNI) Per Capita - China and OECD Member Country Average (1980-2009)

Figure 2-5: Chinese Bureaucratic and Market Divisions (East, Middle, West China)

Figure 2-6: Private Hospitals in China by Region (East / Middle / West) (2010)

Figure 2-7: Number of Private and Public Hospitals in China (1980-2010)

Figure 2-8: Income Sources for Government-Run Hospitals (%)

Figure 2-9: New Rural Cooperative Medical Scheme Enrollment (2004-2010)

Table 2-1: Government-Run Urban Health Insurance Programs in China

Figure 2-10: Government Health Insurance Coverage (2003 and 2008)

Figure 2-11: Hospital Visits in China (millions) (1995-2010)

Table 2-2: Government Healthcare Expenditure and GDP Growth Rates (China and Selected Comparison Countries; 2000-2008

Figure 2-12: Chinese Population by Age (Total; 1990/2000/2009) (%)

CHAPTER THREE: CHINA'S "REFORM" HEALTHCARE MARKET AND ITS SHAPING OF RURAL, URBAN, REGIONAL AND PROVINCIAL MARKETS

Figure 3-1: Chinese Healthcare Reform Government Funding Breakdown (2009-2011)

Figure 3-2: Chinese Rural Healthcare Market by National Market Shares of Province/Direct-Controlled Municipality (2010)

Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)

Table 3-1: Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)

Figure 3-4: Regional Shares of Reimbursement Funds under NRCMS (2010) (East/Middle/West China) (%)

Figure 3-5: Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2010-2015 Projection) (billion yuan)

Table 3-2: Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2010-2015 Projection) (billion yuan)

Table 3-3: Top and Bottom Five Provincial Markets for Rural Healthcare by Gain and Loss in National Market Share (2010-2015)

Figure 3-6: Chinese Urban Healthcare Market by National Market Shares of Province/Direct-Controlled Municipality (2010)

Figure 3-7: Outpatient Visits in the Urban Healthcare Market, 2010 (Hospitals, Community Health Centers, Community Health Stations, Clinics, Other) (millions of visits)

Figure 3-8: Composition of Chinese Hospital Sector by Number of Beds, 2000-2010 (percent)

Figure 3-9: Urban China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)

Table 3-4: Urban China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)

Figure 3-10: Top and Bottom Five Provincial Markets for Urban Healthcare by Gain and Loss in National Market Share (2010-2015)

Figure 3-11: U.S. Medical Product Export Growth to China (1990-2010)

Figure 3-12: Total U.S.-EU Exports to China - Pharmaceutical Products and Medical Devices (2002-2010) (millions of U.S. dollars)

Figure 3-13: Inbound Foreign Direct Investment in Medical Product Manufacturing in China (2002-2010)

Figure 3-14: Foreign-Invested Manufacturing Enterprises in China (1980-2010)

Figure 3-15: Foreign-Invested Manufacturing Enterprises in China by Province/Municipality (1995-2010)

CHAPTER FOUR: DIAGNOSTICS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

Figure 4-1: Chronic Disease Morbidity Rates in Urban China - Hypertension, Diabetes, Cerebrovascular Disease (Stroke), Chronic Obstructive Pulmonary Disease, Heart Disease (per thousand [0/00]) (2003/2008)

Figure 4-2: Chronic Disease Morbidity Rates in Rural China - Hypertension, Diabetes, Stroke, Chronic Obstructive Pulmonary Disease, Heart Disease (2003/2008)

Figure 4-3: Cancer Mortality Rates in China - Lung, Liver, Stomach, Esophageal, Colon, Leukemia, Brain, Breast, Pancreatic (Per 100,000) (2005)

Table 4-1 Incidence Rates for Top Ten Notifiable Infectious Diseases (2010)

Table 4-2 Selected Preventative Medicine Opportunities

Table 4-3 Selected Disease Prevention Programs in China's Healthcare Reform (2009-2011)

Table 4-4 Clinical Labs by Instrumentation Type in BRIC Countries

Figure 4-4: Chinese Market for IVD Reagents ($ millions) (2004-2015)

Figure 4-5: Regional Market Divisions for Medical Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)

Table 4-5 Regional Markets for IVD Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern), 2010-2015

Table 4-6 IVD Market Segmentation (2009) (% of sales)

Table 4-7 IVD Market Shares by Company (2009) (%)

Table 4-8 BRIC IVD Market Comparison (2010) ($ millions)

Table 4-9 Selected Made-in-China Lab Supplies

Table 4-10 Selected IVD Manufacturers in China

Figure 4-6: IVD Product Registration and Regulatory Flowchart

CHAPTER FIVE: MEDICAL DEVICES IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

Figure 5-1: Cancer Mortality Rates in China - Lung, Liver, Stomach, Esophageal, Colon, Leukemia, Brain, Breast, Pancreatic (Per 100,000) (2005)

Figure 5-2: Chinese Population by Age (Total; 1990/2000/2009) (%)

Figure 5-3: Composition of Chinese Hospital Sector by Number of Beds, 2000-2010

Figure 5-4: Compositional Changes in the Hospital Sector - Private, Third-Level and Specialty Hospitals (2005-2010)

Figure 5-5: Chinese Market for Medical Devices ($ billions) (2004-2015)

Figure 5-6: Regional Market Divisions for Medical Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)

Table 5-1 Regional Markets for Medical Devices in China, $ billions 2010 and 2015 (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)

Figure 5-7: China Medical Device Market - Product Segment Shares Percent, 2010 (Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)

Figure 5-8: Foreign-Invested Manufacturing Enterprises in China (1980-2010)

Figure 5-9: Medical Device Registration and Approval Flowchart

CHAPTER SIX: PHARMACEUTICALS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

Figure 6-1: Chronic Disease Morbidity Rates in Urban China - Hypertension, Diabetes, Cerebrovascular Disease (Stroke), Chronic Obstructive Pulmonary Disease, Heart Disease (per thousand [0/00]) (2003/2008)

Figure 6-2: Cancer Mortality Rates in China - Lung, Liver, Stomach, Esophageal, Colon, Leukemia, Brain, Breast, Pancreatic (Per 100,000) (2005)

Table 6-1 Incidence Rates for Top Ten Notifiable Infectious Diseases (2010)

Figure 6-3: Chinese Market for Pharmaceuticals (incl. Hong Kong) ($ billions) (2004-2015)

Figure 6-4: Regional Market Divisions for Medical Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)

Table 6-2 Regional Markets for Pharmaceuticals in China, $ billions, 2010-2015 (Eastern , Northern , Central , Southern , Northeastern , Southwestern , Northwestern )

Figure 6-5: China Pharmaceutical Market - Patented Prescription, Generics, OTC Market Shares (%) (2010)

Table 6-3: China Pharmaceutical Market (Patented Prescription and Generics only) by Product Segment, 2010 and 2015 (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapetuics, Oncology, Respiratory, Other)

Figure 6-6: Foreign-Invested Manufacturing Enterprises in China (1980-2010)

Table 6-4 Leading Medicinal Manufacturers in China (2009) (%, National Share of Aggregate Pharma/TCM/Nutritional Market)

Table 6-5 Pharmaceutical Price Cuts (2000-2010)

Figure 6-7: Pharmaceutical Approval and Regulatory Flowchart

To order this report:

Health Insurance Industry: China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

Health Insurance Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com